Development of dual-enzyme-based simultaneous immunoassay for measurement of progesterone and human chorionic gonadotropin

Progesterone and β-hCG Determination Using an Electrochemical Combo-Strip for Pregnancy Monitoring

The development of analytical devices that can allow an easy, rapid and cost-effective measurement of multiple markers, such as progesterone and β-hCG, could have a role in decreasing the burden associated with pregnancy-related complications, such as ectopic pregnancies. Indeed, ectopic pregnancies are a significant contributor to maternal morbidity and mortality in both high-income and low-income countries. In this work, an effective and highly performing electrochemical strip for a combo determination of progesterone and β-hCG was developed. Two immunosensing approaches were optimized for the determination of these two hormones on the same strip. The immunosensors were realized using cost-effective disposable electrode arrays and reagent-saving procedures. Each working electrode of the array was modified with both the IgG anti-β-hCG and anti-progesterone, respectively. By adding the specific reagents, progesterone or β-hCG can then be determined. Fast quantitative detection was achieved, with the analysis duration being around 1 h. Sensitivity and selectivity were assessed with a limit of detection of 1.5 × 10-2 ng/mL and 2.45 IU/L for progesterone and β-hCG, respectively. The proposed electrochemical combo-strip offers great promise for rapid, simple, cost-effective, and on-site analysis of these hormones and, thus, for the development of a point-of-care diagnostic tool for early detection of pregnancy-related complications.

Advances in human chorionic gonadotropin detection technologies: a review

Human chorionic gonadotropin (HCG) is a glycoprotein secreted by placental trophoblast cells in pregnancy. HCG is a heterodimer composed of two different α- and β-subunits, with the latter being unique to HCG. As well as being the most important diagnostic markers for pregnancy, HCG is also a tumor marker, therefore, quantitative detection of HCG is of great value. Numerous advanced technologies have been developed for HCG concentration detection including electrochemical immunoassay, chemiluminescent immunoassay, fluorescence immunoassay, resonance scattering spectrometry, atomic emission spectrometry, radioimmunoassay, MS and so on. Some have pursued simple and easy operation, while others have emphasized on accuracy and applications in clinical medicine. This review provides a comprehensive summary of various methods of detecting HCG.

Gel pad array chip for high throughput and multi-analyte microbead-based immunoassays

We present here a gel pad array chip for high-throughput and multi-analyte microbead-based immunoassays. The chip is fabricated by photo-patterning of two polymeric gels, polyacrylamide gel and polyethylene glycol (PEG) gel, on a glass slide. The resulting chip consists of 40 polyacrylamide gel pad array units for the immobilization of microbeads and each gel pad array is surrounded with a PEG micropillar ring to confine the samples within the microarray. As a proof of concept, this chip was tested for quantitative immunoassays for two model cancer markers, human chorionic gonadotropin (hCG) and prostate specific antigen (PSA), in serum samples. Detection limits below the physiological threshold level for cancer diagnosis were achieved with good inter- and intra-chip reproducibility. Moreover, by using spatial encoded microbeads, simultaneous detection of both hCG and PSA on each gel pad array is achieved with single filter fluorescence imaging. This gel pad array chip is easy to use, easy to fabricate with low cost materials and minimal equipment and reusable. It could be a useful tool for common biolabs to customize their own microbead array for multi-analyte immunoassays.

Time-resolved chemiluminescence strategy for multiplexed immunoassay of clenbuterol and ractopamine

A novel time-resolved chemiluminescence (CL) strategy was proposed for immunoassay of multiple analytes in a single run. The strategy was performed based on the distinction of the kinetic characteristics of different CL reaction systems, which allowed detection of multiple analytes in different time windows. The strategy was evaluated by using clenbuterol and ractopamine as the model analytes. Horseradish peroxidase (HRP) and alkaline phosphatase (ALP) were adopted as the signal probes to tag the two antigens due to their very different CL kinetic characteristics. After the competitive immunoreactions, the two CL signals were simultaneously triggered by adding the CL coreactants. Then the signals for clenbuterol and ractopamine were in turn detected after 0.6 s and 25 min of the reaction triggering. Due to the distinguishable detection time windows for HRP and ALP, the cross-talk resulting from the mixed CL reaction systems was effectively avoided, which was frequently encountered in some other multiplexed immunoassays based on multi-label modes. The linear ranges for clenbuterol and ractopamine were both 1.0-500 ng/mL, with detection limits of 0.50 ng/mL (S/N=2). The results for real sample analysis demonstrated that this study could provide a simple, low-cost and fast approach toward multiplexed immunoassay.

Antibody-based multiplex analysis of structurally closely related chiral molecules

Four class-specific and stereoselective antibodies were labeled with different fluorophores to enable simultaneous quantification of the enantiomers of phenylalanine and phenyllactic acid. Using fluorescence immunoassays and microarrays, sensitive detection of each analyte was possible even in the presence of a large excess of the other structurally similar molecules.